-Bloomberg
Mix & Match Pfizer, AstraZeneca COVID-19 Vaccine With Moderna Shows Improved Immune Response
A British study evaluating mixing COVID-19 vaccines showed a better immune response in people after the first dose of AstraZeneca
Related Posts
Piper Sandler Maintains Overweight on Enphase Energy, Raises Price Target to $202
Piper Sandler analyst Kashy Harrison maintains Enphase Energy (NASDAQ:ENPH) with a Overweight and raises the price target from $195 to $202.
Here’s How Much $100 Invested In Applied Materials 15 Years Ago Would Be Worth Today
Applied Materials (NASDAQ:AMAT) has outperformed the market over the past 15 years by 4.31% on an annualized basis producing an average annual return of 11.75%. Currently, Applied Materials has a market capitalization of $96.43 billion.
Piper Sandler Maintains Overweight on KORU Medical Systems, Raises Price Target to $4.5
Piper Sandler analyst Jason Bednar maintains KORU Medical Systems (NASDAQ:KRMD) with a Overweight and raises the price target from $3.5 to $4.5.